Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
Recruiting · NCT05772637 · Interventional (participants receive a specific treatment) · Lead sponsor: Assistance Publique - Hôpitaux de Paris
View the official record on ClinicalTrials.gov →Interventions studied
Repeated cystometries with bladder sensations assessment
What this trial is about
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ 18
- MS according to the 2017 Mac Donald diagnostic criteria
- Bladder disorders supposedly related to MS
- Indication to perform urodynamics
- No current medication for bladder disorders
- Able to understand and right in French
- Affiliated to the "Securite sociale" or "Couverture Medicale Universelle (CMU)", or equivalent organism.
Exclusion criteria
- Legal protection
- Pregnancy or breastfeeding mother
- MS relapse during the past month
- Other associated neurological disease
- Genuine stress incontinence related to postpartum
- Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months
- Previous lower urinary tract surgery
- Inability to use the analogic device due to motor, sensory or ataxic disabilities
Where it is running
1 location listed.
- Hôpital TENON - Paris, Choisir Une Région, France